Loading...

RGNT

RGNT

REGENTIS BIOMATERIALS LTD

(RGNT)

2026 6-K

Surgeon Training Launch

8 Jun '26

AGM Notice Update

4 Jun '26

6-K Filing

28 May '26

Financial Results Update

24 Feb '26

European Expansion

17 Feb '26

Management Change

5 Feb '26

Clinical Expansion Announce...

29 Jan '26

Knee Repair Breakthrough

20 Jan '26

Cartilage Repair Innovation

6 Jan '26

Management Change

6 Jan '26

Patent Granted

18 Dec '25

IPO Closure Report

5 Dec '25

External Links:

SEC

On June 8, 2026, Regentis Biomaterials Ltd. announced the commencement of European surgeon training for their GelrinC product, which is aimed at knee cartilage repair as part of their commercial launch preparations. This event is considered significant from an equity investor perspective.

AI Assistant

REGENTIS BIOMATERIALS LTD

2026

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.